Вісник проблем біології і медицини -2024 -Вип. 1 (172) / Bulletin of problems in biology and medicine -2024 -Issue 1 (172)
75ОГЛЯДИ ЛІТЕРАТУРИ / LITERATURE REVIEWS tissue diseases, dysmenorrhea and abnormal uterine bleeding are the most common menstrual disorders, caused by immune dysregulation, autoimmune processes, and inflammation. The modern approach to the treatment of such patients consists in the development of an individual treatment plan, taking into account concomitant diseases, current laboratory findings, pathological features of the onset of the disease and the course of menstrual cycle disorders. Treatment consists of prescribing hormonal (synthetic and natural estrogens, gonadotropin-releasing hormones, progesterone and gonadotropin-releasing hormone analogues) and non-hormonal agents (nonsteroidal anti-inflammatory drugs, tranexamic acid), as well as non-drug treatment (lifestyle modification, physical activity, rational nutrition). To date, there is no unified terminology and generally accepted criteria for diagnosing and assessing the severity of UCTD. Diagnostic methods and criteria for UCTD are not standardized compared to other connective tissue diseases. Management of patients with connective tissue diseases and menstrual dysfunction is a complex issue, the answer to which is based on the assessment of gynecological problems (menstruation, fertility, sexuality) and a multidisciplinary approach involving specialists from other branches.